BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12370405)

  • 1. Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses.
    Roth MD; Cheng Q; Harui A; Basak SK; Mitani K; Low TA; Kiertscher SM
    J Immunol; 2002 Oct; 169(8):4651-6. PubMed ID: 12370405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
    Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
    Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early adenoviral gene expression mediates immunosuppression by transduced dendritic cell (DC): implications for immunotherapy using genetically modified DC.
    Tuettenberg A; Jonuleit H; Tüting T; Brück J; Biermann V; Kochanek S; Knop J; Enk AH
    J Immunol; 2004 Feb; 172(3):1524-30. PubMed ID: 14734730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication and packaging of helper-dependent adenoviral vectors.
    Sato M; Suzuki S; Kubo S; Mitani K
    Gene Ther; 2002 Apr; 9(7):472-6. PubMed ID: 11938462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved vascular gene transfer with a helper-dependent adenoviral vector.
    Wen S; Graf S; Massey PG; Dichek DA
    Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of pulmonary T cell response to helper-dependent adenoviral vectors following intranasal delivery.
    Kushwah R; Cao H; Hu J
    J Immunol; 2008 Mar; 180(6):4098-108. PubMed ID: 18322220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors.
    de Gruijl TD; Luykx-de Bakker SA; Tillman BW; van den Eertwegh AJ; Buter J; Lougheed SM; van der Bij GJ; Safer AM; Haisma HJ; Curiel DT; Scheper RJ; Pinedo HM; Gerritsen WR
    J Immunol; 2002 Nov; 169(9):5322-31. PubMed ID: 12391253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
    Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
    Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.
    Rea D; Havenga MJ; van Den Assem M; Sutmuller RP; Lemckert A; Hoeben RC; Bout A; Melief CJ; Offringa R
    J Immunol; 2001 Apr; 166(8):5236-44. PubMed ID: 11290808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased survival in sepsis by in vivo adenovirus-induced expression of IL-10 in dendritic cells.
    Oberholzer A; Oberholzer C; Bahjat KS; Ungaro R; Tannahill CL; Murday M; Bahjat FR; Abouhamze Z; Tsai V; LaFace D; Hutchins B; Moldawer LL; Clare-Salzler MJ
    J Immunol; 2002 Apr; 168(7):3412-8. PubMed ID: 11907099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination.
    Holst PJ; Ørskov C; Thomsen AR; Christensen JP
    J Immunol; 2010 Apr; 184(8):4431-9. PubMed ID: 20212099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
    Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
    Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.
    Croyle MA; Chirmule N; Zhang Y; Wilson JM
    Hum Gene Ther; 2002 Oct; 13(15):1887-900. PubMed ID: 12396620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.
    Christ M; Lusky M; Stoeckel F; Dreyer D; Dieterlé A; Michou AI; Pavirani A; Mehtali M
    Immunol Lett; 1997 Jun; 57(1-3):19-25. PubMed ID: 9232420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centrifugation enhances integrin-mediated transduction of dendritic cells by conventional and RGD-modified adenoviral vectors.
    Harui A; Roth MD; Sanghvi M; Vira D; Mizuguchi H; Basak SK
    J Immunol Methods; 2006 May; 312(1-2):94-104. PubMed ID: 16626731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha.
    Zhang W; Chen Z; Li F; Kamencic H; Juurlink B; Gordon JR; Xiang J
    Immunology; 2003 Feb; 108(2):177-88. PubMed ID: 12562326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma.
    Gahn B; Siller-Lopez F; Pirooz AD; Yvon E; Gottschalk S; Longnecker R; Brenner MK; Heslop HE; Aguilar-Cordova E; Rooney CM
    Int J Cancer; 2001 Sep; 93(5):706-13. PubMed ID: 11477583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying adenoviral vectors for use as gene-based cancer vaccines.
    Basak SK; Kiertscher SM; Harui A; Roth MD
    Viral Immunol; 2004; 17(2):182-96. PubMed ID: 15279698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.
    Zhu M; Terasawa H; Gulley J; Panicali D; Arlen P; Schlom J; Tsang KY
    Cancer Res; 2001 May; 61(9):3725-34. PubMed ID: 11325845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo.
    Kiener R; Fleischmann M; Schwegler C; Ruzsics Z; Thirion C; Schrödel S; Asbach B; Wagner R
    Sci Rep; 2018 Jan; 8(1):1474. PubMed ID: 29367743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.